Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E
about
Preservation of organ function in head and neck cancer.Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TIRisk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer.Systemic therapy strategies for head-neck carcinomas: Current statusManagement of locally advanced laryngeal cancerT4a laryngeal cancer survival: retrospective institutional analysis and systematic review.Radiosensitizing effect of epothilone B on human epithelial cancer cells.Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects.Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: what are the best predictors of remission and prognosis?Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.Interval between intra-arterial infusion chemotherapy and surgery for locally advanced oral squamous cell carcinoma: impacts on effectiveness of chemotherapy and on overall survival.
P2860
Q30459136-474A73A9-780F-4909-9034-3C13ADCBC3A4Q33397340-29B7A24B-0D7C-4325-B52D-0617EC315949Q33398899-0BBC93A8-7EDC-4865-BB9F-948A2B5ED096Q33412010-2DDFA867-1A8F-4BF9-BF65-2E85DC98630AQ34452702-52E1A735-BD6D-4D13-9599-18277424A7B0Q34564948-BADFDD82-7922-44F0-B9E9-4C0063918C36Q34631324-4AE2C0C3-2080-4CDA-9EBF-9741D51FE55DQ36066977-7403F276-445F-431C-8C2E-3E9C2B7367F7Q36529843-EFEC462D-3F8D-47DB-AC09-41AEEA91E11FQ37539530-01F469A4-B374-4766-A1FF-7F994049FC50Q38171362-1B6C42E8-3E74-4BBA-8F44-C94BA4987C87Q39414221-586A4EB2-14C3-4E51-8D17-2A03B6590041Q45256263-A5BE57EB-242D-45C3-9631-19FA5C4CC918Q45767378-786B13A0-829F-4470-9840-AC7ED8F1617BQ45894356-48D2B332-72BE-48B1-9B19-7F28452D4FD4Q53033729-21A0DAAD-D0B4-453F-A7D3-AD15F200D797Q54450580-78083FD0-6E9B-451D-96DF-63CFCC71D97EQ55564237-7A790278-363E-4CDA-BF1E-76DFBB0F8457
P2860
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. E
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@ast
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@en
type
label
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@ast
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@en
prefLabel
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@ast
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@en
P2093
P2860
P1476
Feasibility, toxicity, and eff ...... larynx, and base of tongue. E
@en
P2093
Frank Waldfahrer
Gunther Klautke
Heinrich Iro
Michael Lell
Michael Uder
Rainer Linke
Sabine Semrau
Torsten Kuwert
P2860
P2888
P356
10.1007/S00066-010-2178-2
P577
2010-12-22T00:00:00Z
P6179
1015374298